Access cutting-edge advanced cervical cancer treatment through this clinical trial at a research site in Hackensack. Study-provided care at no cost to qualified participants.
Access advanced cervical cancer specialists in Hackensack at no cost
This study follows strict safety protocols and ethical guidelines
All study-related advanced cervical cancer treatment provided free
This is a phase II trial of combination therapy of pembrolizumab and lenvatinib in patients with locally advanced or metastatic cervical cancer that had failed first line of therapy. The hypothesis is the combination of lenvatinib and pembrolizumab will overcome vascular endothelial growth factor (VEGF)-mediated immunosuppression to enhance the response of patients with locally advanced or metastatic cervical cancer.
Sponsor: Georgetown University
Check if you qualify for this advanced cervical cancer clinical trial in Hackensack, NJ
If you're searching for advanced cervical cancer treatment options in Hackensack, NJ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Hackensack research site is actively enrolling participants for this clinical trial. You'll receive care from experienced advanced cervical cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.